These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10910024)

  • 1. Push-pull sorbent-based pheresis and hemodiabsorption in the treatment of hepatic failure: preliminary results of a clinical trial with the BioLogic-DTPF System.
    Ash SR; Steczko J; Knab WR; Blake DE; Carr DJ; Harker KD; Levy H
    Ther Apher; 2000 Jun; 4(3):218-28. PubMed ID: 10910024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Powdered sorbent liver dialysis and pheresis in treatment of hepatic failure.
    Ash SR
    Ther Apher; 2001 Oct; 5(5):404-16. PubMed ID: 11778927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Push-pull sorbent based pheresis for treatment of acute hepatic failure: the BioLogic-detoxifier/plasma filter System.
    Ash SR; Blake DE; Carr DJ; Harker KD
    ASAIO J; 1998; 44(3):129-39. PubMed ID: 9617941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracorporeal blood detoxification by sorbents in treatment of hepatic encephalopathy.
    Ash SR
    Adv Ren Replace Ther; 2002 Jan; 9(1):3-18. PubMed ID: 11927902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of hemodiabsorption and sorbent-based pheresis on amino acid levels in hepatic failure.
    Steczko J; Bax KC; Ash SR
    Int J Artif Organs; 2000 Jun; 23(6):375-88. PubMed ID: 10919755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokines and endotoxin removal by sorbents and its application in push-pull sorbent-based pheresis: the BioLogic-DTPF System.
    Steczko J; Ash SR; Blake DE; Carr DJ; Bosley RH
    Artif Organs; 1999 Apr; 23(4):310-8. PubMed ID: 10226695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of systemic inflammatory response syndrome by push-pull powdered sorbent pheresis: a Phase 1 clinical trial.
    Ash SR; Steczko J; Levy H; Blake DE; Carr DJ
    Ther Apher; 2001 Dec; 5(6):497-505. PubMed ID: 11800089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic inflammatory response syndrome treatment by powdered sorbent pheresis: the BioLogic-Detoxification Plasma Filtration System.
    Levy H; Ash SR; Knab W; Steczko J; Carr DJ; Blake DE
    ASAIO J; 1998; 44(5):M659-65. PubMed ID: 9804517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Push-pull sorbent-based pheresis treatment in an experimental canine endotoxemia model: preliminary report.
    Peter AT; Ash SR; Steczko J; Turek JJ; Blake DE; Carr DJ; Knab WR; Bosley RH
    Int J Artif Organs; 1999 Mar; 22(3):177-88. PubMed ID: 10357246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodiabsorption in treatment of hepatic failure.
    Wilkinson AH; Ash SR; Nissenson AR
    J Transpl Coord; 1998 Mar; 8(1):43-50. PubMed ID: 9726220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodiabsorption in treatment of acute hepatic failure and chronic cirrhosis with ascites.
    Ash SR
    Artif Organs; 1994 May; 18(5):355-62. PubMed ID: 8037609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of treatment with the Molecular Adsorbents Recirculating System on arterial amino acid levels and cerebral amino acid metabolism in patients with hepatic encephalopathy.
    Schmidt LE; Tofteng F; Strauss GI; Larsen FS
    Scand J Gastroenterol; 2004 Oct; 39(10):974-80. PubMed ID: 15513337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of a phase I trial evaluating a liver support device utilizing albumin dialysis.
    Awad SS; Swaniker F; Magee J; Punch J; Bartlett RH
    Surgery; 2001 Aug; 130(2):354-62. PubMed ID: 11490371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of sorbent suspension dialysis on plasma amino acid levels in cirrhotic patients with refractory hepatic encephalopathy.
    Bauer E; Gendo A; Madl C; Garo F; Roth E; Kramer L
    Int J Artif Organs; 2002 Oct; 25(10):923-8. PubMed ID: 12456032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of an albumin dialysate hemodiafiltration system for the clearance of unconjugated bilirubin.
    Awad SS; Rich PB; Kolla S; Younger JG; Reickert CA; Downing VP; Bartlett RH
    ASAIO J; 1997; 43(5):M745-9. PubMed ID: 9360145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical effects of a sorbent suspension dialysis system in treatment of hepatic coma (the BioLogic-DT).
    Ash SR; Blake DE; Carr DJ; Carter C; Howard T; Makowka L
    Int J Artif Organs; 1992 Mar; 15(3):151-61. PubMed ID: 1521900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Charcoal-based hemodiabsorption liver support for episodic type C hepatic encephalopathy.
    Hill K; Hu KQ; Cottrell A; Teichman S; Hillebrand DJ
    Am J Gastroenterol; 2003 Dec; 98(12):2763-70. PubMed ID: 14687830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of sorbent-based dialytic therapy with the BioLogic-DT on an experimental model of hepatic failure.
    Ash SR; Carr DJ; Blake DE; Rainier JB; Demetriou AA; Rozga J
    ASAIO J; 1993; 39(3):M675-80. PubMed ID: 8268623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous veno-venous single-pass albumin hemodiafiltration in children with acute liver failure.
    Ringe H; Varnholt V; Zimmering M; Luck W; Gratopp A; König K; Reich S; Sauer IM; Gaedicke G; Querfeld U
    Pediatr Crit Care Med; 2011 May; 12(3):257-64. PubMed ID: 20921923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Albumin dialysis improves hepatic encephalopathy and decreases circulating phenolic aromatic amino acids in patients with alcoholic hepatitis and severe liver failure.
    Parés A; Deulofeu R; Cisneros L; Escorsell A; Salmerón JM; Caballería J; Mas A
    Crit Care; 2009; 13(1):R8. PubMed ID: 19175915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.